Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer

Hepato-Gastroenterology

Volumn 60, Issue 123, 2013, Pages 432-438

  Sundov, Zeljko ^a   Tomic, Snjezana ^a   Alfirevic, Stanko ^b   Sundov, Ana ^c   Capkun, Vesna ^b   Nincevic, Zeljko ^d   Nincevic, Jasna ^e   Kunac, Nenad ^a   Kontic, Miso ^d   Poljak, Nikola ^d   Druzijanic, Nikica ^a  

^a UNIVERSITY OF SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

^c UNIVERSITY OF MOSTAR   (Bosnia and Herzegovina)

^d UNIVERSITY HOSPITAL SPLIT   (Croatia)

^e Pub Hlth Inst Split Dalmatian Co   (Croatia)

Author keywords

Colon cancer; Immunohistochemistry; LVD; MVD; Vascular invasion

Indexed keywords

CD34 ANTIBODY;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CAPILLARY DENSITY; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, CD31; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MICROVESSELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; VESICULAR TRANSPORT PROTEINS;

EID: 84879589451     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12826     Document Type: Article

References (38)

1. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 1999; 49:3-64.
2. Ferlay F, Bray P, Pisani DM. Parkin J: GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5. Version 2.O., Lyon, IARC Press, 2004.
3. Strnad M, Znaor A (Ur.): Preživljenje oboljelih od raka u Hr-vatskoj, 1988-1998/Cancer survival in Croatia 1988-1998; Zagreb, Hrvatski zavod za javno zdravstvo, 2006.
4. Stemmerman GN: Patterns of disease among Japanese living in Hawai. Arch Envirom Health 1970; 20:266-273.
5. Palmer S: Dietary considerations for risk reduction. Cancer 1986;58:199-204.
6. Barozzi C, Ravaioli M, D'Enriko A, et al.: Relevance of Biological Markers in Colorectal Carcinoma. A Comparative Study of a Broad Panel. Cancer 2002;94:647-57. (Pubitemid 34132292)
7. Kumar V, Abbas AK, Fausto N: Robbins and Corran Pathologic Basis of Disease. Philadelphia: Elsevier Saunders 2005, 309-313.
8. Boxer GM, Tsiompanou E, Levine T, Watson R, Begent RH: Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer. Tumour Biol 2005; 26:1-8. (Pubitemid 40529292)
9. Kerbel R, Folkman J: Clinical translation of angiogenesis inhibitors. Nature Rev Cancer 2002; 2:727-739. (Pubitemid 37328908)
10. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angio-genesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
11. Weidner N: Current pathologic methods for measuring intratumoral microvessel within breast carcinoma and other solid tumors. Breast Cancer Res 1995; 36:169-180.
12. Guetz GD, Uzzan B, Nicolas P, et al.: Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 2006; 94:1823-1832. (Pubitemid 43882572)
13. Takahashi Y, Bucana CD, Cleary KR, Ellis LM: P53, vessel count and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 1998; 79:34-38. (Pubitemid 28157723)
14. Tabara H, Kohno H, Dhar DK, et al.: Concurrent Expression of Angiogenic Growth Factors and Neovascularisation during Tumourigenesis in Colorectal Carcinoma Patients. Acta Oncol 2001;40:622-628. (Pubitemid 32912441)
15. Offersen BV, Borre M, Overgaard J: Quantification of angio-genesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 2003; 39:881-890. (Pubitemid 36428619)
16. Vermeulen PB, Gasparini G, Fox SB, et al.: Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002; 38:1564-1579. (Pubitemid 34876495)
17. Stacker SA, Baldwin ME, Achen MG: Role of tumor lymphangiogenesis in metastatic spread. FASEB) 2002; 16:922-934. (Pubitemid 34753498)
18. Kaio E, Tanaka S, Kitadai Y, et al.: Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology 2003; 64:61-73. (Pubitemid 35477956)
19. Wang TB, Huang YH, Lan P, Song XM, Wang JP: Correlation of lymphangiogenesis to progression of colorectal cancer. Ai Zheng 2005; 24:1276-1279.
20. Banerji S, Ni J, Wang SX, et al.: LYVE-1, a new homologue of the CD44 glycoprtein, is a lymph- specific receptor for hyaluronan. J Cell Biol 1999; 144:789-801. (Pubitemid 29234556)
21. Lee JY, Spicer AP: Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol 2000; 12:581-586.
22. Jakson DG: Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 2004; 112:526-538.
23. Straume O, Jackson DG, Akslen LA: Independent Prognostic Impact of Lymphatic Vessel Density and Presence of Low-Grade Lymphangiogenesis in Cutaneous Melanoma. Clin Cancer Res 2003; 9:250-256. (Pubitemid 36109741)
24. Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Yokoo T, Ishii T: Toho Study Group for Cancer Biological Behavior. Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer 2008; 112:924-933. (Pubitemid 351240587)
25. Duff SE, Jeziorska M, Kumar S, et al.: Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer. Colorectal Dis 2007; 9(9):793-800. (Pubitemid 47578025)
26. Liang JT, Huang KC, Jeng YM, Lee PH, Lai HS, Hsu HC: Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer. Br J Surg. 2004; 91(3):355-361.
27. Masunaga R, Kohno H, Dhar DK, et al.: Cyclooxygenase-2 expression correlates wth tumor neovascularisation and prognosis in human colorectal carcinoma patients. Clin Canc Res 2000; 6:4064-4068.
28. Bossi P, Viale G, Lee AK, Alfano R, Coggi G, Bosari S: Angio-genesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 1995; 55:5049-5053.
29. Martin L: Standardising of methodology of vessel density in breast cancer using immunochistochemistry and tumor micro-angiography. Breast 1995; 4:227-257.
30. Yan G, Zhou XY, Cai SJ, Zhang GH, Peng JJ, Du X: Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World J Gastroenterol 2008; 7(14):101-107. (Pubitemid 351314335)
31. Wang JM, Kumar S, Pye D, Haboubi N, al-Nakib L: Breast carcinoma: Comparative study of tumor vasculature using endothelial cell. Markers. J Natl Cancer Inst 1994; 86:386-388. (Pubitemid 24076881)
32. Vermeulen PB, Gasparini G, Fox SB: Quantification of angio-genesis in solid human tumors: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996; 32:2472-2484.
33. Kern A, Taubert H, Scheele J, et al.: Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases. Int J Oncol 2002; 21:243-249.
34. Kuroyama S, Kobayashi N, Ohbu M, Ohtani Y, Okayasu I, Kakita A: Enzyme histochemical analysis of lymphatic vessels in colon carcinoma: occurrence of lymphangiogenesis within the tumor. Hepatogastroenterology 2005; 52:1057-1061. (Pubitemid 40942184)
35. Padera TP, Kadambi A, di Tomaso E, et al.: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002; 296:1883-1886. (Pubitemid 34596277)
36. Jia YT, Li ZX, He YT, Liang W, Yang HC, Ma HJ: Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer. World J Gastroenterol 2004; 10:3261-3263. (Pubitemid 39585461)
37. Mou JH, Yan XC, Li ZP, et al.: Characteristic and clinicopathologic significance of lymphangiogenesis in colorectal cancer. Zhonghua Bing Li Xue Za Zhi 2005; 34:348-352.
38. Figueredo A, Coombes ME, Mukherjee S: Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 2008; 16(3):CD005390.